Write in a clean editor, then format for Gynecologic Oncology Reports in one click — DocuGuru applies the official Elsevier template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Gynecologic Oncology Reports is a peer-reviewed journal published by Elsevier, covering Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Uterine Myomas and Treatments.
| Publisher | Elsevier |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Gynecologic Oncology Reports, 12(3), pp. 45–58.
Formats any DOI in Gynecologic Oncology Reports style. No sign-up. |
| Publishes research in | Endometrial and Cervical Cancer Treatments Ovarian cancer diagnosis and treatment Uterine Myomas and Treatments Cervical Cancer and HPV Research Sarcoma Diagnosis and Treatment |
| ISSN | 2352-5789 |
| Citation impact (2-yr) | 1.06 |
| h-index | 38 |
| i10-index | 361 |
| Total citations | 11,927 |
| Article processing charge | $650 |
| Open access | Yes |
| Top institutions publishing here | Cornell University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The global cervical cancer burden falls disproportionately upon women in low and middle-income countries. Insufficient infrastructure, lack of access to preventive HPV vaccines, screening, and treatment, as well as limited trained personnel and training opportunities, continue to impede efforts to reduce incidence and mortality in these nations. These hurdles have been substantial challenges to radiation…
Since the initial recognition of acquired immunodeficiency syndrome (AIDS) in 1981, an increased burden of cervical cancer was identified among human immunodeficiency virus (HIV)-positive women. Introduction of antiretroviral therapy (ART) decreased risks of opportunistic infections and improved overall survival. HIV-infected women are living longer. Introduction of the human papillomavirus (HPV) vaccine, cervical cancer screening and…
Cervical cancer is the leading cause of cancer death among women in Uganda. Given the high prevalence of genital human papillomavirus infection, the current unavailability of radiotherapy, and the absence of a national cervical cancer prevention and control program, these deaths will likely increase. Efforts to organize an effective cervical cancer screening and treatment program…
To address gaps in access to cervical cancer screening and early diagnosis of breast cancer services in Sub-Saharan African (SSA), this scoping review was conducted to explore facilitators and barriers that exist on the patient-, provider-, and system-level. An extensive literature search was conducted in accordance with scoping review methodology and the Cochrane guidelines. Our…
To identify the frequency of BRCA mutation in patients with high grade epithelial ovarian cancer (EOC). Patients with EOC included fallopian tube cancer or peritoneal cancer with high grade serous or high grade endometrioid were recruited. BRCA1 and BRCA2 mutations were tested and analyzed by next generation sequencing system. A total of 87 patients were…
